Analyst Ratings for Century Therapeutics (IPSC)
IPSC Rating Summary
IPSC Price Target Summary
- Highest: $6.60 (Clear Street)
- Lowest: $2.00 (Leerink Partners)
- Average: $4.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.20 (+64.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$4.20 (+64.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | TD Cowen | Phil Nadeau | New Coverage | Buy (N/A) |
N/A (N/A) |
2.13 (2.56) |
20.19% | Details |
| 11/17/2025 | Leerink Partners | Daina Graybosch | Downgrade | Market Perform (Outperform) |
2.00 (7.00) |
0.47 (2.56) |
444.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
